Cargando…

SMYD2 aggravates gastrointestinal stromal tumor via upregulation of EZH2 and downregulation of TET1

SMYD2, as an oncogene, has been involved in multiple types of cancer, but the potential role of SMYD2 in gastrointestinal stromal tumors (GIST) remains enigmatic and requires further investigation. Hence, this study was conducted with the main objective of analyzing the effect of SMYD2 on GIST. GIST...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Yong, Xu, Xiaofeng, Long, Cong, Wang, Jianjiang, Ding, Li, Zheng, Zhizhong, Wu, Huiping, Yang, Liu, Tao, Lan, Gao, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170715/ https://www.ncbi.nlm.nih.gov/pubmed/35668081 http://dx.doi.org/10.1038/s41420-022-01038-w

Ejemplares similares

EZH2 and SMYD3 expression in papillary thyroid cancer
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2021)

Correlations of EZH2 and SMYD3 gene polymorphisms with breast cancer susceptibility and prognosis
por: Ma, Shao-Jun, et al.
Publicado: (2018)

Downregulation of MEG3 and upregulation of EZH2 cooperatively promote neuroblastoma progression
por: Ye, Mujie, et al.
Publicado: (2022)

Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders
por: Muto, Tomoya, et al.
Publicado: (2013)

Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma
por: Binh, Mai Thanh, et al.
Publicado: (2020)

Analysis of TET2 and EZH2 gene functions in chromosome instability in acute myeloid leukemia
por: Wang, Jingyi, et al.
Publicado: (2020)

EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions
por: Alzrigat, Mohammad, et al.
Publicado: (2016)

SMYD2 Inhibition Downregulates TMPRSS2 and Decreases SARS-CoV-2 Infection in Human Intestinal and Airway Epithelial Cells
por: Yu, Yu-Qiang, et al.
Publicado: (2022)

SMYD2 promoter DNA methylation is associated with abdominal aortic aneurysm (AAA) and SMYD2 expression in vascular smooth muscle cells
por: Toghill, Bradley J., et al.
Publicado: (2018)

The Attenuation of Trophoblast Invasion Caused by the Downregulation of EZH2 Is Involved in the Pathogenesis of Human Recurrent Miscarriage
por: Lv, Shijian, et al.
Publicado: (2018)

TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2(−/−)-Driven Myeloid Malignancy Progression
por: Li, Rong, et al.
Publicado: (2017)

Upregulation of TET1 and downregulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients
por: Dong, E, et al.
Publicado: (2012)

SMYD2 glutathionylation contributes to degradation of sarcomeric proteins
por: Munkanatta Godage, Dhanushka N. P., et al.
Publicado: (2018)

Histone methyltransferase SMYD2: ubiquitous regulator of disease
por: Yi, Xin, et al.
Publicado: (2019)

LINC00565 promotes the progression of colorectal cancer by upregulating EZH2
por: Shao, Xiaxia, et al.
Publicado: (2021)

STAT3 promotes chronic lymphocytic leukemia progression through upregulating SMYD3 expression
por: Ma, Wei, et al.
Publicado: (2018)

Epigenetic upregulation of TET2 is an independent poor prognostic factor for intrahepatic cholangiocarcinoma
por: Yamashita, Hironori, et al.
Publicado: (2021)

TET2 Protects against oxLDL-Induced HUVEC Dysfunction by Upregulating the CSE/H(2)S System
por: Peng, Juan, et al.
Publicado: (2017)

Tet methylcytosine dioxygenase 2 inhibits atherosclerosis via upregulation of autophagy in ApoE(−/−) mice
por: Peng, Juan, et al.
Publicado: (2016)

Endogenous epitope-tagging of Tet1, Tet2 and Tet3 identifies TET2 as a naïve pluripotency marker
por: Pantier, Raphaël, et al.
Publicado: (2019)

Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer
por: Yu, Yong, et al.
Publicado: (2019)

Cardiac Deletion of Smyd2 Is Dispensable for Mouse Heart Development
por: Diehl, Florian, et al.
Publicado: (2010)

Overexpression of SMYD2 contributes to malignant outcome in gastric cancer
por: Komatsu, S, et al.
Publicado: (2015)

Characterizing the Role of SMYD2 in Mammalian Embryogenesis—Future Directions
por: Jarrell, Dillon K., et al.
Publicado: (2020)

Downregulation of lncRNA CCDC26 contributes to imatinib resistance in human gastrointestinal stromal tumors through IGF-1R upregulation
por: Yan, Jingyi, et al.
Publicado: (2019)

TET Upregulation Leads to 5-Hydroxymethylation Enrichment in Hepatoblastoma
por: Rivas, Maria Prates, et al.
Publicado: (2019)

Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
por: Thomenius, Michael J., et al.
Publicado: (2018)

Playing on the Dark Side: SMYD3 Acts as a Cancer Genome Keeper in Gastrointestinal Malignancies
por: Sanese, Paola, et al.
Publicado: (2021)

Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma
por: Zuo, Shan-Ru, et al.
Publicado: (2018)

Physioxia-induced downregulation of Tet2 in hematopoietic stem cells contributes to enhanced self-renewal
por: Aljoufi, Arafat, et al.
Publicado: (2022)

Loss of TET2 impairs endothelial angiogenesis via downregulating STAT3 target genes
por: Shi, Yefei, et al.
Publicado: (2023)

EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis
por: Shih, C-H, et al.
Publicado: (2017)

EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma
por: Xue, Liqiong, et al.
Publicado: (2019)

Polyploidy, EZH2 upregulation, and transformation in cytomegalovirus-infected human ovarian epithelial cells
por: El Baba, Ranim, et al.
Publicado: (2023)

Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN()()
por: Nakakido, Makoto, et al.
Publicado: (2015)

SMYD2 promotes cervical cancer growth by stimulating cell proliferation
por: Sun, Jun-Jie, et al.
Publicado: (2019)

The lysine methyltransferase SMYD5 amplifies HIV-1 transcription and is post-transcriptionally upregulated by Tat and USP11
por: Boehm, Daniela, et al.
Publicado: (2023)

The function and regulation of TET2 in innate immunity and inflammation
por: Cong, Boyi, et al.
Publicado: (2020)

The role of EZH1 and EZH2 in development and cancer
por: Lee, Soo Hyun, et al.
Publicado: (2022)

Downregulation of miR-186 is associated with metastatic recurrence of gastrointestinal stromal tumors
por: Niinuma, Takeshi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a94s03g5dmkk83fovrr3sg67qr